Stay updated on M7824 and Eribulin in Metastatic TNBC Clinical Trial
Sign up to get notified when there's something new on the M7824 and Eribulin in Metastatic TNBC Clinical Trial page.

Latest updates to the M7824 and Eribulin in Metastatic TNBC Clinical Trial page
- Check3 days agoChange DetectedThe page now shows Revision: v3.0.2 (replacing v3.0.1), and the 'Back to Top' link has been removed.SummaryDifference0.2%
- Check11 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%
- Check18 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, as well as the introduction of new drug names such as Eribulin Mesylate and bintrafusp alfa protein. However, several related topics and previous drug names have been removed.SummaryDifference2%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check39 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check47 days agoChange DetectedThe web page has been updated to version 2.16.10, and the previous service alert regarding planned maintenance has been removed.SummaryDifference0.9%
Stay in the know with updates to M7824 and Eribulin in Metastatic TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the M7824 and Eribulin in Metastatic TNBC Clinical Trial page.